NeurogesX (NGSX) Taps Advisor in Evaluating Development Objectives

NeurogesX, Inc. (Nasdaq: NGSX), has engaged JSB-Partners, a global life sciences advisor, to assist the Company in executing its business development objectives that include selecting potential development and commercial partners and entering into partnerships for the United States and other major global markets, which remain unpartnered, for its lead product candidate NGX-1998 and its commercialized product Qutenza® (capsaicin 8%) patch.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• Real and RE/MAX Holdings receive court approval for merger
• Kimbell Royalty closes $221.2M mineral rights acquisition